Results 161 to 170 of about 5,743 (215)

Molecular pharmacokinetic mechanism of JBP485 against aristolochic acid I (AAI) -induced nephrotoxicity. [PDF]

Front Pharmacol
Wang C, Jin H, Wang C, Wu J, Meng Q, Zhong M, Sun H, Wei Y, Gao G, Kaku T, Huo X, Liu K.   +11 more
europepmc   +1 more source

Pharmacokinetics and Drug Interactions. [PDF]

Pharmaceutics
Choi MK, Song IS.
europepmc   +1 more source

Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]

Curr Ther Res Clin Exp
Yu J, Argon S, Owens K, Wang Y, Ragueneau-Majlessi I.   +4 more
europepmc   +1 more source

Human and rat renal proximal tubule in vitro models for ADME applications. [PDF]

Arch Toxicol
Klatt OC, de Brouwer L, Hendriks F, Dehne EM, Ataç Wagegg B, Jennings P, Wilmes A.   +6 more
europepmc   +1 more source

Innovative modeling: a diet-induced quail model for progressive pathological changes in uric acid metabolism disorders. [PDF]

Front Nutr
Xu Y, Wang Y, Gao F, Lu C, Liu S, Chen S, Zhang X, Lin Z, Zhang B.   +8 more
europepmc   +1 more source

Contracts II (Sect. A): Final Examination (May 21, 1971)

, 1971
William & Mary Law School
core